Cargando…

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34(−) and immature CD34(+) cells

Accumulation in target cells is an essential pharmacokinetic step of targeted therapies. Tyrosine Kinase Inhibitors (TKI) against the BCR-ABL fusion protein in Chronic Phase-Chronic Myeloid Leukaemia (CP-CML) cells constitute a unique model in terms of efficacy, specificity, and in vivo demonstratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Marc G., Lebecque, Benjamin, Tassin, Thomas, Dannus, Louis-Thomas, Berger, Juliette, Soucal, Mélanie, Guerci, Agnès, Cony-Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Guyotat, Denis, Gagnieu, Marie-Claude, Pereira, Bruno, Saugues, Sandrine, Tournilhac, Olivier, Hermet, Eric, Bourgne, Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969931/ https://www.ncbi.nlm.nih.gov/pubmed/33731863 http://dx.doi.org/10.1038/s41598-021-85734-0

Ejemplares similares

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34(+) CD15(−) cells in early chronic‐phase chronic myeloid leukemia
por: Maupetit‐Mehouas, Stéphanie, et al.
Publicado: (2018)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib
por: Genthon, Alexis, et al.
Publicado: (2020)

Similar expression profiles in CD34(+) cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib
por: Patel, Ami B., et al.
Publicado: (2018)

DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
por: Lebecque, Benjamin, et al.
Publicado: (2021)

Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study
por: Pungolino, Ester, et al.
Publicado: (2021)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

Nilotinib Enhances the Efficacy of Conventional Chemotherapeutic Drugs in CD34(+)CD38(−) Stem Cells and ABC Transporter Overexpressing Leukemia Cells
por: Wang, Fang, et al.
Publicado: (2014)

Applicability of the long‐term uncertainty in measurement (LTUM) method for analytical performance assessment in clinical cytometry laboratories
por: Dannus, Louis‐Thomas, et al.
Publicado: (2021)

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment
por: Trojani, Alessandra, et al.
Publicado: (2019)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Experimental treatment of stroke in spontaneously hypertensive rats by CD34(+ )and CD34(-) cord blood cells
por: Boltze, Johannes, et al.
Publicado: (2005)

Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells
por: Belle, Ludovic, et al.
Publicado: (2012)

CD34+/CD38- Stem Cell Burden Could Predict Chronic Myeloid Leukemia Patients’ Outcome
por: Fathy El-Metwaly, Noura, et al.
Publicado: (2021)

Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis
por: Mitroi, Mihaela, et al.
Publicado: (2019)

Correlations between CD34 Immunolabelled Blood Vessels and CD34 mRNA Expression in Colorectal Cancer
por: TOMA, S.C., et al.
Publicado: (2018)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Plerixafor for autologous CD34(+) cell mobilization
por: Salman, Huda, et al.
Publicado: (2011)

Transplantation of CD34+ cells for myocardial ischemia
por: Matta, Anthony, et al.
Publicado: (2021)

Role of CD34 in inflammatory bowel disease
por: Li, Zhiyuan, et al.
Publicado: (2023)

Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib: A case report
por: Shu, Yefei, et al.
Publicado: (2018)

Human Pluripotent Stem Cells Differentiated in Fully Defined Medium Generate Hematopoietic CD34(+) and CD34(−) Progenitors with Distinct Characteristics
por: Chicha, Laurie, et al.
Publicado: (2011)

CD34(−) Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-α Expression in CD34(+) Fibroblasts and Fibrocytes
por: Lu, Yan, et al.
Publicado: (2018)

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
por: Plesa, Adriana, et al.
Publicado: (2017)

In vitro effects of imatinib on CD34(+) cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
por: MENG, FANKAI, et al.
Publicado: (2014)

Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients
por: Ricciardi, Maria Rosaria, et al.
Publicado: (2018)

Mitochondrial oxidative phosphorylation is dispensable for survival of CD34(+) chronic myeloid leukemia stem and progenitor cells
por: Yan, Jin-Song, et al.
Publicado: (2022)

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
por: Jiang, Zhiwu, et al.
Publicado: (2016)

Expression of CD34 and CD31 in Central and Peripheral Giant Cell Granulomas
por: Sadri, Donia, et al.
Publicado: (2019)

Purification of Human CD34(+)CD90(+) HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy
por: Radtke, Stefan, et al.
Publicado: (2020)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

CD34 Expression in the Stromal Cells of Alveolar Adenoma
por: De Rosa, Nicolina, et al.
Publicado: (2012)

Transplantation of Immortalized CD34+ and CD34- Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses
por: Kim, Jong-Ho, et al.
Publicado: (2016)

Vasoprotective effects of human CD34+ cells: towards clinical applications
por: Kiernan, Thomas J, et al.
Publicado: (2009)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

Survival outcomes of CD34(+)CD38(−)LSCs and their expression of CD123 in adult AML patients
por: Zahran, Asmaa M., et al.
Publicado: (2018)

Expression of adhesion molecules on CD34+ cells from steady-state bone marrow before and after mobilization and their association with the yield of CD34+ cells
por: Cecyn, Karin Zattar, et al.
Publicado: (2018)

Differentially expressed genes responsible for insensitivity of CD34+ cells to kinase inhibitors in patients with chronic myeloid leukemia
por: Moreira-Nunes, Caroline FA, et al.
Publicado: (2013)

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

An Immunohistochemical Survey to Evaluate the Expression of CD105 and CD34 in Ameloblastoma and Odontogenic Keratocyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q2i6d2drhbrb90m713qe7fd2i6